US Diabetes Devices Market Accelerates with Tech-Driven Solutions for Type 1 & Type 2 Diabetes Management | Expected to Reach US$ 18.93 Billion by 2033

"The US Diabetes Devices Market reached US$ 10.25 billion in 2024 and is expected to reach US$ 18.93 billion by 2033, growing at a CAGR of 7.1% during the forecast period 2025-2033." As per DataM intelligence research report

Market growth opportunities(2025-2031):

The U.S. diabetes devices market is positioned for steady expansion through 2030, as innovations in personalized care and integrated platforms drive adoption. Expansion of over-the-counter continuous glucose monitors (CGMs) and insulin delivery systems broadens access beyond traditional insulin-dependent users. Interoperable closed-loop systems combining CGMs, pumps, and AI-enhanced algorithms are increasingly available for both type 1 and type 2 patients. Smart, connected devices with mobile app integrations enhance trend-based therapy adjustments and remote patient coaching. Elevated payer coverage and digital health partnerships also underpin robust uptake across diverse patient cohorts.

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/us-diabetes-devices-market?sp

US Diabetes Devices Market: Recent Industry Developments

✅ In July 2025, Dexcom launched the G8 Continuous Glucose Monitor (CGM) in the U.S., featuring predictive alerts, faster warm-up times, and Bluetooth 6.0 connectivity. It aims to improve glucose control with greater accuracy and seamless smartphone integration.

✅ In June 2025, Insulet Corporation began full U.S. rollout of its Omnipod 5 Automated Insulin Delivery system for type 2 diabetes. The wearable, tubeless pump uses adaptive algorithms and CGM input to adjust insulin in real-time, supporting easier self-management.

✅ In May 2025, Abbott's FreeStyle Libre 3 received CMS reimbursement expansion, making the CGM available to more Medicare patients with type 2 diabetes not on insulin. This move significantly increases access to real-time glucose data for high-risk populations.

✅ In April 2025, Medtronic secured FDA approval for its MiniMedTM 780G insulin pump, designed with Meal DetectionTM technology and automatic corrections. The device allows users to stay within range even with occasional missed boluses.

✅ In March 2025, Tandem Diabetes Care introduced the t:slim X3 pump platform, featuring advanced cybersecurity, longer battery life, and full interoperability with future CGM systems. It sets the stage for next-gen, personalized insulin delivery.

US Diabetes Devices Market: Drivers

Key drivers include the growing prevalence of diabetes in the U.S., particularly type 2, which is increasing the number of individuals needing daily monitoring and therapy support. Advances in sensor technology and miniaturization have enabled the development of more accurate, comfortable, and user-friendly devices. Regulatory approval of over-the-counter CGMs and automated insulin delivery systems is simplifying patient access. Expanded insurance coverage, including Medicare support for CGMs and insulin caps, is accelerating adoption among older adults and underserved populations. Furthermore, the rise of telehealth and digital health platforms is encouraging the use of remote-monitoring-compatible devices, fostering better adherence and long-term glycemic control.

Strategic Players Driving the US Diabetes Devices Market Forward:

F. Hoffmann-La Roche Ltd, Abbott Laboratories, Medtronic plc, Terumo Corporation, B. Braun SE, Insulet Corporation, Nipro Corporation, Johnson & Johnson Services, Inc., Senseonics, Inc., Tandem Diabetes Care, Inc. and among others.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/us-diabetes-devices-market?sp

Segment Covered in the US Diabetes Devices Market:

➥By Product Type: Blood Glucose Monitoring Devices, Insulin Delivery Devices, Others
➥By End-User: Hospitals, Specialty Clinics, Homecare Settings, Diagnostic Centers, Others

Regional Analysis for US Diabetes Devices Market:

The United States remains the largest and most technologically advanced diabetes devices market globally. It leads in product innovation, clinical adoption, and regulatory support for device-based diabetes care. The market benefits from a strong infrastructure, high awareness, and widespread availability of digital and home-based healthcare services. Increasing investments in digital therapeutics and hybrid care delivery models are reinforcing the U.S. position as a global hub for diabetes device innovation.

Why Purchase the Report for US Diabetes Devices Market?:

➠ Technology & Innovation: Tracks clinical trials and upcoming pharmaceutical advancements to stay ahead in product development.
➠ Market Positioning & Competitive Strategy: Analyzes product performance, market share, and competitor tactics for strategic decision-making.
➠ Real-World Evidence & Physician Insights: Incorporates patient data and physician behavior to align products with actual healthcare needs.
➠ Pricing & Market Access: Reviews reimbursement trends and access models to optimize product pricing and launch strategies.
➠ Regulatory & Industry Shifts: Covers policy changes, health system dynamics, and technology trends impacting market opportunities.
➠ Regional Growth & Expansion: Identifies high-growth markets and investment opportunities for geographic expansion.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=us-diabetes-devices-market?sp

Conclusion:

The U.S. diabetes devices market continues to evolve rapidly, with technology-driven innovation and personalized care at its core. The integration of AI, real-time monitoring, and connected platforms is improving both patient experience and treatment outcomes. Growth is supported by a favorable policy landscape, increasing consumer demand for self-care solutions, and a shift toward preventive, data-driven diabetes management. Companies that focus on accessibility, simplicity, and interoperability will be best positioned to succeed in this dynamic market.

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.